Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: results from the BIOBADASER register
19/12/2023
Juan Molina-Collada, Fernando Alonso, Lucía Otero, Cristina Bohórquez, César Díaz Torné, Carolina Pérez García, Juan M. Blanco Madrigal, Paloma Vela, José María Álvaro-Gracia Isabel Castrejón, BIOBADASER group
Seminars in Arthritis and Rheumatism
https://doi.org/10.1016/j.semarthrit.2023.152341
doi: 10.1016/j.semarthrit.2023.152341